- NEWS AND VIEWS
A spatial perspective on bacteria in tumours
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Nature 611, 674-675 (2022)
Galeano Niño, J. L. et al. Nature 611, 810–817 (2022).
Farc, O. & Cristea, V. Exp. Ther. Med. 21, 96 (2021).
Hirata, E. & Sahai, E. Cold Spring Harb. Perspect. Med. 7, a026781 (2017).
Petitprez, F., Meylan, M., de Reyniès, A., Sautès-Fridman, C. & Fridman, W. H. Front. Immunol. 11, 784 (2020).
Nejman, D. et al. Science 368, 973–980 (2020).
Poore, G. D. et al. Nature 579, 567–574 (2020).
Dohlman, A. B. et al. Cell Host Microbe 29, 281–298 (2021).
Narunsky-Haziza, L. et al. Cell 185, 3789–3806 (2022).
Dohlman, A. B. et al. Cell 185, 3807–3822 (2022).
Cullin, N., Azevedo Antunes, C., Straussman, R., Stein-Thoeringer, C. K. & Elinav, E. Cancer Cell 39, 1317–1341 (2021).
Sepich-Poore, G. D. et al. Science 371, eabc4552 (2021).
Hanahan, D. Cancer Discov. 12, 31–46 (2022).
Wang, S. et al. Front. Cell Dev. Biol. 9, 710165 (2021).
Castellarin, M. et al. Genome Res. 22, 299–306 (2012).
Gallaher, J. A., Brown, J. S. & Anderson, A. R. A. Sci. Rep. 9, 2425 (2019).
R.S. is a paid consultant and has stock interest in Micronoma, CuResponse, Biomica and Baccine. He is a paid consultant to Merk - Sigma-Aldrich, Israel, and for City of hope, USA. He is a member of the scientific advisory board of Micronoma; received a grant from Merck EMD Serono; and is a co-inventor on multiple patents related to the use of intratumour microbes as diagnostic or prognostic markers or for therapeutic opportunities.